Ryvit develops integration software tailored for the construction industry. Its platform facilitates seamless data flow between various premise-based and cloud software applications, including enterprise resource products, CRM, e-commerce platforms, social apps, and industry-specific systems. Headquartered in Saint Louis, Missouri, Ryvit empowers businesses to automate workflows and optimize application usage without straining development resources.
Kypha
Venture Round in 2017
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
OPER
Venture Round in 2017
Founded in 2015, OPER is a St. Louis-based company offering a mobile platform for restaurant payments and rewards. It enables customers to order food, pay directly through the app, and earn rewards, while restaurants benefit from streamlined operations, enhanced customer experiences, and data-driven insights.
Adarza BioSystems
Series C in 2017
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.
Kypha
Venture Round in 2017
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Label Insight
Venture Round in 2016
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Founded in 2015, OPER is a St. Louis-based company offering a mobile platform for restaurant payments and rewards. It enables customers to order food, pay directly through the app, and earn rewards, while restaurants benefit from streamlined operations, enhanced customer experiences, and data-driven insights.
Kypha
Venture Round in 2016
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Adarza BioSystems
Series B in 2016
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.
Label Insight
Series B in 2016
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Kypha
Debt Financing in 2015
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Label Insight
Venture Round in 2015
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Label Insight
Convertible Note in 2015
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Kypha
Convertible Note in 2015
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Tunespeak
Series A in 2015
Founded in 2011 and headquartered in St. Louis, Missouri, Tunespeak operates a musician-to-fan loyalty platform. Its platform enables users to earn points by engaging with music content such as listening to songs, watching videos, browsing photos, and sharing with friends.
Label Insight
Series A in 2014
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Kypha
Venture Round in 2014
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Label Insight
Series A in 2014
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.
Kypha
Venture Round in 2014
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.
Adarza BioSystems
Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.